Bente Arboe

489 total citations
12 papers, 279 citations indexed

About

Bente Arboe is a scholar working on Pathology and Forensic Medicine, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bente Arboe has authored 12 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 5 papers in Neurology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bente Arboe's work include Lymphoma Diagnosis and Treatment (11 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (3 papers). Bente Arboe is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (3 papers). Bente Arboe collaborates with scholars based in Denmark. Bente Arboe's co-authors include Peter de Nully Brown, Tarec Christoffer El‐Galaly, Jette Sønderskov Gørløv, Michael Roost Clausen, Paw Jensen, Pär Josefsson, Tobias Wirenfeldt Klausen, Jacob Haaber Christensen, Peter Svenssen Munksgaard and Judit Jørgensen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Bente Arboe

12 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bente Arboe Denmark 7 202 123 60 57 43 12 279
Stewart Coltart United Kingdom 6 205 1.0× 147 1.2× 88 1.5× 36 0.6× 67 1.6× 7 281
Erica Linden United States 8 101 0.5× 116 0.9× 30 0.5× 36 0.6× 68 1.6× 12 374
Eric Mou United States 9 144 0.7× 104 0.8× 51 0.8× 28 0.5× 32 0.7× 27 213
L. Casanova Peru 7 132 0.7× 193 1.6× 47 0.8× 39 0.7× 48 1.1× 12 314
P. Brice France 7 164 0.8× 134 1.1× 73 1.2× 49 0.9× 107 2.5× 15 315
Erin Zagadailov United States 12 76 0.4× 100 0.8× 18 0.3× 95 1.7× 36 0.8× 31 336
Anne Cowppli‐Bony France 12 75 0.4× 159 1.3× 33 0.6× 42 0.7× 106 2.5× 17 351
Jan‐Peter Glossmann Germany 10 167 0.8× 179 1.5× 92 1.5× 59 1.0× 51 1.2× 18 339
Jelena Jelicic Serbia 11 206 1.0× 99 0.8× 66 1.1× 87 1.5× 24 0.6× 38 317
Zeena Salman United States 10 268 1.3× 158 1.3× 23 0.4× 304 5.3× 34 0.8× 27 576

Countries citing papers authored by Bente Arboe

Since Specialization
Citations

This map shows the geographic impact of Bente Arboe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bente Arboe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bente Arboe more than expected).

Fields of papers citing papers by Bente Arboe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bente Arboe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bente Arboe. The network helps show where Bente Arboe may publish in the future.

Co-authorship network of co-authors of Bente Arboe

This figure shows the co-authorship network connecting the top 25 collaborators of Bente Arboe. A scholar is included among the top collaborators of Bente Arboe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bente Arboe. Bente Arboe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Arboe, Bente, Maja Halgren Olsen, Jette Sønderskov Gørløv, et al.. (2019). <p>Treatment intensity and survival in patients with relapsed or refractory diffuse large B-cell lymphoma in Denmark: a real-life population-based study</p>. Clinical Epidemiology. Volume 11. 207–216. 14 indexed citations
2.
Arboe, Bente, Maja Halgren Olsen, Jette Sønderskov Gørløv, et al.. (2017). Return to work for patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation. Clinical Epidemiology. Volume 9. 321–329. 13 indexed citations
3.
4.
Jakobsen, Lasse Hjort, Martin Bøgsted, Peter de Nully Brown, et al.. (2017). Minimal Loss of Lifetime for Patients With Diffuse Large B-Cell Lymphoma in Remission and Event Free 24 Months After Treatment: A Danish Population-Based Study. Journal of Clinical Oncology. 35(7). 778–784. 63 indexed citations
5.
Arboe, Bente, Pär Josefsson, Christian Poulsen, et al.. (2016). Rituximab Maintenance after First Line Immunochemotherapy Improves Overall Survival in Patients with Follicular Lymphoma. Blood. 128(22). 1781–1781. 2 indexed citations
6.
Arboe, Bente, Pär Josefsson, Judit Jørgensen, et al.. (2016). Danish National Lymphoma Registry. Clinical Epidemiology. Volume 8. 577–581. 47 indexed citations
7.
Arboe, Bente, Tarec Christoffer El‐Galaly, Michael Roost Clausen, et al.. (2016). The Danish National Lymphoma Registry: Coverage and Data Quality. PLoS ONE. 11(6). e0157999–e0157999. 82 indexed citations
8.
Arboe, Bente, Maja Halgren Olsen, Susanne Oksbjerg Dalton, et al.. (2016). Social Outcomes after High Dose Chemotherapy with Autologous Stem Cell Transplant. Blood. 128(22). 1193–1193. 1 indexed citations
9.
Arboe, Bente, et al.. (2015). The Danish Lymphoma Registry has a high coverage and high data quality. Haematologica. 100. 2 indexed citations
10.
Arboe, Bente, et al.. (2014). Evaluation of the decision support system for antimicrobial treatment, TREAT, in an acute medical ward of a university hospital. International Journal of Infectious Diseases. 29. 156–161. 13 indexed citations
11.
Mylam, Karen Juul, Martin Bøgsted, Peter de Nully Brown, et al.. (2014). Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non‐Hodgkin and Hodgkin lymphoma. American Journal of Hematology. 89(6). 575–580. 37 indexed citations
12.
El‐Galaly, Tarec Christoffer, Karen Juul Mylam, Maria Rossing, et al.. (2013). Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse. Hematological Oncology. 31. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stewart Coltart Breakdown of academic impact, for papers by Erica Linden Breakdown of academic impact, for papers by Eric Mou Breakdown of academic impact, for papers by L. Casanova Breakdown of academic impact, for papers by P. Brice Breakdown of academic impact, for papers by Erin Zagadailov Breakdown of academic impact, for papers by Anne Cowppli‐Bony Breakdown of academic impact, for papers by Jan‐Peter Glossmann Breakdown of academic impact, for papers by Jelena Jelicic Breakdown of academic impact, for papers by Zeena Salman
Rankless by CCL
2026